Using gene-edited mice with humanised GLP-1 receptors, the team found that oral small-molecule GLP-1 drugs activated the central amygdala, a region associated with desire and reward that sits deeper in the brain than the hypothalamic and hindbrain networks where injectable peptide GLP-1s have been shown to act
Despite the low inhibitory potency of these inhibitors, also compounds from this class have been studied in the clinic
Koska J, Sands M, Burciu C, D'Souza KM, Raravikar K, Liu J, Truran S, Franco DA, Schwartz EA, Schwenke DC
Ultimately, the cycle of innovation that once centered around the hospital is now extending beyond its walls
The Little Health Law Blogs three-point compounding checklist is a practical starting point for this audit
Real GLP-1 programs have labs, follow-ups, and providers who can spot side effects early and adjust treatment